Transaction details
On February 27, 2026, Universal Technical Institute (NASDAQ: UTI) Chief Executive Officer Jerome Alan Grant sold 60,040 shares of the company's common stock. The shares were disposed of at prices ranging from $34.41 to $35.115, with a weighted average sale price of $34.9516. The total value of the transaction was $2,098,494. Following the sale, Grant retains direct ownership of 430,215 shares of Universal Technical Institute.
Stated reason and market context
The company disclosed that the sale was executed for personal tax planning purposes. The transaction came as UTI shares were trading near the stock's 52-week high of $37.57. The shares have risen 43% year-to-date.
Valuation perspective
According to InvestingPro analysis included in the company's reporting, UTI appears overvalued at current levels, with the stock trading at a price-to-earnings ratio of 38.46. That metric is presented alongside the transaction and recent operating results as part of the market context investors are seeing.
Recent financial results and analyst view
Universal Technical Institute reported mixed outcomes for the first quarter of fiscal 2026. The company recorded earnings per share of $0.23, narrowly missing analysts' consensus of $0.24. Revenue, however, exceeded expectations, with Universal Technical Institute reporting $220.8 million versus a projected $216.81 million.
Against that backdrop, Truist Securities reiterated its Buy rating on Universal Technical Institute and left its price target unchanged at $40.00. The research firm highlighted expectations for an acceleration in student enrollment starts, which it views as a potential driver of future growth for the company.
Takeaway
The insider sale, described as tax-related, coincides with UTI trading near multi-month highs and with mixed operational signals for the latest quarter - a slight EPS shortfall alongside a revenue beat and an analyst view that anticipates enrollment momentum.